COMPREHENSIVE PRACTICE EXAM:
PHARMACOTHERAPEUTICS FOR APRNS
QUESTIONS WITH ANSWERS &
RATIONALES
Section 1: Basic Principles of Pharmacology (Questions 1-15)
Question 1
A patient with hepatic cirrhosis has decreased albumin production. The
APRN understands that this condition will most likely affect drug
therapy by:
A) Decreasing drug metabolism, leading to toxicity
B) Increasing free drug concentration of highly protein-bound drugs
C) Decreasing renal excretion of water-soluble drugs
D) Increasing first-pass metabolism
Correct Answer: B
Rationale: Albumin is the primary protein for binding acidic drugs. In
cirrhosis, hypoalbuminemia reduces protein binding sites, resulting in
,higher free (unbound) active drug levels, which increases the risk of
toxicity even with standard doses.
Question 2
A drug with a half-life of 24 hours is administered once daily.
Approximately how long will it take to reach steady state?
A) 24 hours
B) 48 hours
C) 5 days
D) 10 days
Correct Answer: C
Rationale: Steady state is achieved after approximately 4-5 half-
lives. With a 24-hour half-life, steady state is reached in about 4-5
days (96-120 hours).
Question 3
Which of the following drug properties would result in the highest
bioavailability after oral administration?
A) Extensive first-pass metabolism
B) Poor solubility in gastric fluids
C) High lipophilicity with minimal first-pass effect
D) Active transport back into intestinal lumen by P-glycoprotein
Correct Answer: C
Rationale: High lipophilicity allows drug to cross cell membranes
,easily. Minimal first-pass metabolism means more drug reaches
systemic circulation unchanged, resulting in high bioavailability.
Question 4
The APRN is prescribing a drug that is a weak acid with a pKa of 4.5.
Where will this drug be most readily absorbed?
A) Stomach (pH 1.5-2.5)
B) Small intestine (pH 6-7)
C) Colon (pH 7-8)
D) Rectum (pH 7-8)
Correct Answer: A
Rationale: Weak acids are non-ionized (lipid-soluble) in acidic
environments. At stomach pH (1.5-2.5), which is well below the pKa of
4.5, the drug remains predominantly non-ionized and readily absorbed
across gastric membranes.
Question 5
A patient is taking Warfarin and begins taking a new medication that is
a strong CYP2C9 inhibitor. The APRN should anticipate:
A) Decreased Warfarin levels and reduced INR
B) Increased Warfarin levels and elevated INR
C) No change in Warfarin levels
D) Increased Warfarin metabolism and lower INR
Correct Answer: B
Rationale: Warfarin is metabolized by CYP2C9. Inhibition of this
, enzyme reduces Warfarin metabolism, leading to higher drug levels,
increased anticoagulant effect, and elevated INR, which increases
bleeding risk.
Question 6
Which pharmacokinetic process is most affected by reduced renal
function in an elderly patient?
A) Absorption
B) Distribution
C) Metabolism
D) Elimination
Correct Answer: D
Rationale: Renal excretion is the primary route of elimination for
many drugs and their metabolites. Age-related decline in glomerular
filtration rate (GFR) directly reduces drug elimination, requiring dose
adjustment for renally cleared medications.
Question 7
The APRN understands that a drug with a narrow therapeutic index:
A) Has a wide margin of safety
B) Requires frequent serum level monitoring
C) Cannot be given orally
D) Is always administered once daily
Correct Answer: B
Rationale: Narrow therapeutic index drugs (e.g., lithium, digoxin,
PHARMACOTHERAPEUTICS FOR APRNS
QUESTIONS WITH ANSWERS &
RATIONALES
Section 1: Basic Principles of Pharmacology (Questions 1-15)
Question 1
A patient with hepatic cirrhosis has decreased albumin production. The
APRN understands that this condition will most likely affect drug
therapy by:
A) Decreasing drug metabolism, leading to toxicity
B) Increasing free drug concentration of highly protein-bound drugs
C) Decreasing renal excretion of water-soluble drugs
D) Increasing first-pass metabolism
Correct Answer: B
Rationale: Albumin is the primary protein for binding acidic drugs. In
cirrhosis, hypoalbuminemia reduces protein binding sites, resulting in
,higher free (unbound) active drug levels, which increases the risk of
toxicity even with standard doses.
Question 2
A drug with a half-life of 24 hours is administered once daily.
Approximately how long will it take to reach steady state?
A) 24 hours
B) 48 hours
C) 5 days
D) 10 days
Correct Answer: C
Rationale: Steady state is achieved after approximately 4-5 half-
lives. With a 24-hour half-life, steady state is reached in about 4-5
days (96-120 hours).
Question 3
Which of the following drug properties would result in the highest
bioavailability after oral administration?
A) Extensive first-pass metabolism
B) Poor solubility in gastric fluids
C) High lipophilicity with minimal first-pass effect
D) Active transport back into intestinal lumen by P-glycoprotein
Correct Answer: C
Rationale: High lipophilicity allows drug to cross cell membranes
,easily. Minimal first-pass metabolism means more drug reaches
systemic circulation unchanged, resulting in high bioavailability.
Question 4
The APRN is prescribing a drug that is a weak acid with a pKa of 4.5.
Where will this drug be most readily absorbed?
A) Stomach (pH 1.5-2.5)
B) Small intestine (pH 6-7)
C) Colon (pH 7-8)
D) Rectum (pH 7-8)
Correct Answer: A
Rationale: Weak acids are non-ionized (lipid-soluble) in acidic
environments. At stomach pH (1.5-2.5), which is well below the pKa of
4.5, the drug remains predominantly non-ionized and readily absorbed
across gastric membranes.
Question 5
A patient is taking Warfarin and begins taking a new medication that is
a strong CYP2C9 inhibitor. The APRN should anticipate:
A) Decreased Warfarin levels and reduced INR
B) Increased Warfarin levels and elevated INR
C) No change in Warfarin levels
D) Increased Warfarin metabolism and lower INR
Correct Answer: B
Rationale: Warfarin is metabolized by CYP2C9. Inhibition of this
, enzyme reduces Warfarin metabolism, leading to higher drug levels,
increased anticoagulant effect, and elevated INR, which increases
bleeding risk.
Question 6
Which pharmacokinetic process is most affected by reduced renal
function in an elderly patient?
A) Absorption
B) Distribution
C) Metabolism
D) Elimination
Correct Answer: D
Rationale: Renal excretion is the primary route of elimination for
many drugs and their metabolites. Age-related decline in glomerular
filtration rate (GFR) directly reduces drug elimination, requiring dose
adjustment for renally cleared medications.
Question 7
The APRN understands that a drug with a narrow therapeutic index:
A) Has a wide margin of safety
B) Requires frequent serum level monitoring
C) Cannot be given orally
D) Is always administered once daily
Correct Answer: B
Rationale: Narrow therapeutic index drugs (e.g., lithium, digoxin,
